Lazard (LAZ) stock is back in focus after the company added veteran investment banker Kathy Elsesser to its Board of Directors, succeeding long serving director Andrew M. Alper following his retirement.
See our latest analysis for Lazard.
The board refresh comes as Lazard’s share price has moved sharply in the very short term, with a 1 day share price return of 4.19% and a 7 day share price return of 7.21%, while the 30 day share price return is down 6.64% and the year to date share price return is down 12.99%, set against a 3 year total shareholder return of 56.72% that points to longer term investors having fared better overall than those focused on recent moves.
If this governance update has you thinking about where else leadership and execution might matter most, it could be a good moment to scan 20 top founder-led companies
The recent bounce in Lazard after a weak year to date still leaves a clear tension. Does the current price and discount to estimated value stack the risk reward in favor of buyers, or is the upside already reflected?
Most Popular Narrative: 17.8% Undervalued
The most followed narrative on Lazard compares a fair value of $52.63 to the last close at $43.28. This frames a wide gap that hinges on ambitious growth and profitability assumptions.
Analysts are assuming Lazard's revenue will grow by 12.9% annually over the next 3 years. Analysts assume that profit margins will increase from 8.4% today to 11.4% in 3 years time.
Want to see what justifies that gap between price and fair value? The narrative focuses on faster earnings growth, rising margins and a re-rated profit multiple. Curious which assumptions really carry the valuation story?
Result: Fair Value of $52.63 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Lazard's push into new regions and products could lift costs faster than revenues. At the same time, any slowdown in advisory backlogs might challenge the upbeat narrative.
Find out about the key risks to this Lazard narrative.
Next Steps
Lazard’s story clearly has both supporters and skeptics, so this is a good time to review the evidence yourself and decide where you stand. To weigh up the upside alongside the concerns that investors are flagging, check out the full breakdown of 3 key rewards and 2 important warning signs
Looking for more investment ideas beyond Lazard?
If Lazard has sharpened your focus on opportunity and risk, do not stop here. Broaden your watchlist with other ideas that fit your style and goals.
- Target resilient stability by checking out companies in the 74 resilient stocks with low risk scores that may align with a more defensive approach.
- Hunt for potential mispricing by scanning the 41 high quality undervalued stocks for stocks where fundamentals and price look out of sync.
- Spot future standouts early by reviewing the screener containing 18 high quality undiscovered gems before the wider market pays attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com